Survival analysis results indicated that a higher proportion of CD8+TILs in colon cancer was associated with a better prognosis of the patients (Fig. 2G, HR = 0.381, 95% CI: 0.184–0.792, P = 0.018). Here, CD8A is linked to malignant colon neoplasm.